NDC 0121-0914-05 - Childrens Ibuprofen Oral Suspension
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0121-0914
- Requested NDC
- 0121-0914-05
- Package NDCs from labels
- 0121-0914-05, 0121-0914-00
- Manufacturer
- Pharmaceutical Associates, Inc. | G&W Industries, Inc.
- Effective date
- 2022-08-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Children's Ibuprofen Oral Suspension USP | Pharmaceutical Associates, Inc. | G&W Industries, Inc. | 2022-08-31 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0121-0914-00 | Childrens Ibuprofen Oral Suspension | 10 in 1 TRAY | SUSPENSION | 10 | 5 | |
| 0121-0914-00 | Childrens Ibuprofen Oral Suspension | 10 in 1 CASE | SUSPENSION | 10 | 5 | |
| 0121-0914-05 | Childrens Ibuprofen Oral Suspension | 5 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 5 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0121-0914-00 | ML - Milliliter | 0121-0914 | 672c74ba-f41e-4e62-890d-bd98f5e0dd0f | 1 | 2020-08-06 |
| 0121-0914-05 | ML - Milliliter | 0121-0914 | 2a3f142d-5657-4a2a-afce-0c051390796c | 1 | 2020-08-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| dual action | ACETAMINOPHEN, IBUPROFEN | Rite Aid Corporation | 54b08d24-d5e9-4111-9d97-329896e8309d | 2026-09-09 | Warnings | WK2XYI10QM |
| Leader Eye Drops Redness Relief | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Cardinal Health | aee4bbe2-4f11-4c54-be8b-df48b3ba4f3a | 2026-09-09 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | Lidl US LLC | 0ca02f8b-4413-4e7c-a67b-8c67c53e1343 | 2026-09-09 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | GOODSENSE | 596a1007-08ea-00ec-e063-6394a90a5eb2 | 2026-09-09 | Warnings | WK2XYI10QM |
| ibuprofen childrens | IBUPROFEN | Rite Aid Corporation | c6e68886-edcb-414d-9cba-0d97772ef8b6 | 2026-09-09 | Warnings | 197803 WK2XYI10QM |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Rite Aid Corporation | 407c78ca-6fee-4ed6-b61b-711ec049c86e | 2026-09-09 | Warnings | PDC6A3C0OX |
| Ibuprofen minis | IBUPROFEN | The Kroger Co. | 15709fa7-114b-453c-b63d-f1c4f28f0f95 | 2026-09-08 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | REMEDYREPACK INC. | 2144eff0-d7ab-486d-b116-a4ff3ae2afe2 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Clear Eyes Nighttime | GLYCERIN | Prestige Brands Holdings, Inc. | af75e2f7-81dd-43e0-a390-b52bbfbebf62 | 2026-09-08 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | The Kroger Co. | a7789f7f-3356-463b-9fd7-2d7f7eba2799 | 2026-09-08 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | Amazon.com Services LLC | 90659e83-d989-46a5-9680-3a4f61612511 | 2026-09-04 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Direct_Rx | 40071818-5bf0-095b-e063-6294a90ad58a | 2026-09-04 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | CVS Pharmacy | 3167c918-a7d3-46a1-a85b-64f9c22916f2 | 2026-09-04 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | Chain Drug Marketing Association, Inc. | 8d518a08-486a-4d11-b042-27fc1e6060c9 | 2026-09-03 | Warnings | WK2XYI10QM |
| IBUPROFEN Immediate Release | IBUPROFEN | Strides Pharma Inc | a5dd275f-f388-44ec-8297-74430a742d52 | 2026-09-02 | Boxed warning, Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PD-Rx Pharmaceuticals, Inc. | 0fa4cd66-66ad-4ec9-b38c-6b5840df39df | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen Immediate Release | IBUPROFEN | Strides Pharma Inc | ebcc4da3-d0f6-4e40-99b5-e88310ea4a5b | 2026-09-02 | Boxed warning, Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | REMEDYREPACK INC. | 99730c4a-d2ee-46f5-91f4-a15cbaace40d | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PD-Rx Pharmaceuticals, Inc. | 3a38add6-a114-4e18-836c-3bfc727db231 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | REMEDYREPACK INC. | 404df13d-4ada-4324-9eed-e21f5d5043a4 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.